1-(6-[3]-ladderane-hexanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphoethanolamine



Compound IDCDAMM00232
Common name1-(6-[3]-ladderane-hexanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphoethanolamine
IUPAC name[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[8-(10-tetracyclo[6.4.0.02,7.03,6]dodecanyl)octoxy]propyl] 6-(10-tetracyclo[6.4.0.02,7.03,6]dodecanyl)hexanoate
Molecular formulaC43H72NO7P

Experimental data

Retention time39.8
Adduct[M+Na]+
Actual mz768.494
Theoretical mz768.494
Error0.58
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.1774

Identifiers and class information

Inchi keyRNZKRCZDBYPIQC-GIKLQGNPNA-N
SmilesC1CC2C(CC1CCCCCCCCOC(COC(=O)CCCCCC3CCC4C(C3)C5C4C6C5CC6)COP(=O)(O)OCCN)C7C2C8C7CC8
SuperclassLipids and lipid-like molecules
ClassGlycerophospholipids

Pharmacokinetic properties

Number of descriptor values(#stars)11
Number of non-conjugated amine groups (#amine)1
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)1
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)26
Number of reactive functional groups (#rtvFG)3
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)746.018
Computed dipole moment(dipole)7.317
Total solvent accessible surface area (SASA)1356.71
Hydrophobic component of SASA (FOSA)1215.44
Hydrophilic component of SASA (FISA)139.198
Pie component of the SASA (PISA)0
Weakly polar component of the SASA (WPSA)2.078
Total solvent accesible volume (volume)2535.06
Number of hydrogen bond donors (donorHB)3
Number of hydrogen bond acceptors (accptHB)9.7
Free energy of solvation of dipole (dip^2/V)0.0211188
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0123835
Globularity descriptor (glob)0.662731
Predicted polarizability in cubic angstroms (QPpolrz)78.605
Predicted hexadecane/gas partition coefficient (QPlogPC16)25.434
Predicted octanol/gas partition coefficient (QPlogPoct)34.962
Predicted water/gas partition coefficient (QPlogPw)12.145
Predicted octanol/water partition coefficient (QPlogPo/w)7.919
Predicted aqueous solubility (QPlogS)-12.102
Conformation-independent predicted aqueous solubility (CIQPlogS)-8.228
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.908
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)29.949
Predicted brain/blood partition coefficient (QPlogBB)-2.713
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)16.114
Predicted skin permeability, log Kp (QPlogKp)-3.651
PM3 calculated ionization potential (IP(ev))8.939
PM3 calculated electron affinity (EA(eV))0.142
Number of likely metabolic reactions (#metab)4
Prediction of binding to human serum albumin (QPlogKhsa)2.1
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)73.819
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)120.577
Number of nitrogen and oxygen atoms (#NandO)8
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P43657LPAR6Lysophosphatidic acid receptor 6T13484SEA
Q9UPC5GPR34Probable G-protein coupled receptor 34T73859SEA
O00398P2RY10Putative P2Y purinoceptor 10T00488SEA
Q9BXC1GPR174Probable G-protein coupled receptor 174T87661SEA
Q9UBY5LPAR3Lysophosphatidic acid receptor Edg-7T95923SEA
Q92633LPAR1Lysophosphatidic acid receptor Edg-2T92640SEA
P16885PLCG2Phospholipase C-gamma-2T93922SEA
Q99677LPAR4Lysophosphatidic acid receptor 4T58130SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T95923DI0146Fibrosis[ICD-11: GA14-GC01]Q9UBY5LPAR3
T95923DI0399Systemic sclerosis[ICD-11: 4A42]Q9UBY5LPAR3
T92640DI0146Fibrosis[ICD-11: GA14-GC01]Q92633LPAR1
T92640DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]Q92633LPAR1
T92640DI0351Psoriasis[ICD-11: EA90]Q92633LPAR1
T92640DI0399Systemic sclerosis[ICD-11: 4A42]Q92633LPAR1

Copyright © 2025